# TG Therapeutics, Inc.: Form DEF 14A, filed May 1, 2023

- Company: [TG Therapeutics, Inc.](/companies/tgtx.md) (CIK 1001316)
- Form: DEF 14A
- Filed: 2023-05-01
- Accepted by EDGAR: May 1, 2023, 16:17 ET
- Period: not reported
- Accession: 0001558370-23-007490
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001316/000155837023007490/tgtx-20230614xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001316/000155837023007490/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001316/000155837023007490/tgtx-20230614xdef14a.htm

Filed May 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-007490. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.